CTS (NYSE:CTS – Get Free Report) issued its quarterly earnings results on Tuesday. The electronics maker reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.06, Zacks reports. The business had revenue of $132.42 million for the quarter. CTS had a return on equity of 11.98% and a net margin of 10.70%. During the same period in the previous year, the company posted $0.54 earnings per share. CTS updated its FY24 guidance to $2.05-2.25 EPS and its FY 2024 guidance to 2.050-2.250 EPS.
CTS Stock Performance
NYSE CTS traded up $1.03 on Wednesday, hitting $50.76. 213,569 shares of the company’s stock traded hands, compared to its average volume of 148,927. The firm’s 50-day moving average price is $47.77 and its two-hundred day moving average price is $49.14. The firm has a market capitalization of $1.56 billion, a PE ratio of 29.48 and a beta of 0.57. The company has a current ratio of 3.41, a quick ratio of 2.85 and a debt-to-equity ratio of 0.12. CTS has a 1-year low of $35.50 and a 1-year high of $55.47.
CTS Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.04 dividend. The ex-dividend date was Friday, September 27th. This represents a $0.16 annualized dividend and a yield of 0.32%. CTS’s dividend payout ratio (DPR) is presently 9.41%.
Analyst Upgrades and Downgrades
About CTS
CTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia. The company provides encoders, rotary position sensors, slide potentiometers, industrial and commercial rotary potentiometers. It also provides non-contacting, and contacting pedals; and eBrake pedals.
Read More
- Five stocks we like better than CTS
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Best Stocks Under $5.00
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for CTS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CTS and related companies with MarketBeat.com's FREE daily email newsletter.